KATHERINE HERNANDEZ: Open Payments
NPI 1316683824 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,383 in 206 payments from 21 companies in 2025. Trend: 2023 $856 · 2024 $3,132 · 2025 $4,383
Food & beverage: $4,110Education: $273
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $550 |
| Incyte Corporation | 19 | $537 |
| ABBVIE INC. | 21 | $422 |
| Galderma Laboratories, L.P. | 11 | $376 |
| PFIZER INC. | 15 | $347 |
| UCB, Inc. | 11 | $295 |
| Regeneron Healthcare Solutions, Inc. | 10 | $278 |
| GENZYME CORPORATION | 9 | $245 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $200 |
| Organon LLC | 12 | $179 |
Products named: TREMFYA, OPZELURA, DUPIXENT, CIBINQO, SKYRIZI, NEMLUVIO, Bimzelx, Zoryve.
Industry payments across FL — which companies pay providers there.
